| (210) | Number of the EPO application | 17823319 |
| (220) | Filing date of the EPO application | 2017.12.13 |
| (80) | EPO patent specification publication (B) | EPB nr. 43/2022, 2022.10.26 |
| (110) | EPO patent number | 3554536 |
| (21) | Number of the application | e 2019 1196 |
| (71) | Name(s) of applicant(s), code of the country | Boehringer Ingelheim Animal Health USA Inc., US; |
| (72) | Name(s) of inventor(s), code of the country | BUBLOT Michael, FR;
MEBATSION Teshome, US;
PRITCHARD Joyce, US;
LINZ Perry, US;
KASSA Aemro, US; |
| (73) | Name(s) of owner(s), code of the country | Boehringer Ingelheim Animal Health USA Inc., US; |
| (54) | Title of the invention | RECOMBINANT HVT VECTORS EXPRESSING MULTIPLE ANTIGENS OF AVIAN PATHOGENS, AND VACCINES COMPRISING THEM |
| (13) | Kind-of-document code | A1 |
| (51) | International Patent Classification | A61K 39/12 (2006.01.01); A61K 39/155 (2006.01.01); A61K 39/245 (2006.01.01); A61K 39/295 (2006.01.01); C07K 14/03 (2006.01.01); C07K 14/08 (2006.01.01); C12N 7/00 (2006.01.01) |
| (19) | Country | US |
| (41) | Date of publication of the application | 2019.12.31 |
| (30) | Priority | 201662433842 P, 2016.12.14, US |
| (86) | International application | PCT/US2017/066139, 2017.12.13 |
| (87) | International publication | WO 2018/112051, 2018.06.21 |